FrancophonIA/ELRC3.0 huggingface dataset:
English: What are the risks associated with Stayveer?
Slovenian: Kakšna tveganja so povezana z zdravilom Stayveer?
English: Other information about Stayveer
Slovenian: Druge informacije o zdravilu Stayveer
English: By expanding these blood vessels, pressure is reduced and symptoms are improved.
Slovenian: Z razširitvijo krvnih žil se tlak zniža in simptomi izboljšajo.
English: The second study which also looked at the effect of Stayveer on digital ulcer healing in 190 patients did not find any effect.
Slovenian: V drugi študiji, v kateri so prav tako proučevali učinek zdravila Stayveer na celjenje razjed prstov pri 190 bolnikih, se ni pokazal nikakršen učinek.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Stayveer have also been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in previdnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Stayveer upoštevati zdravstveni delavci in bolniki, so vključeni tudi v povzetek glavnih značilnosti zdravila in navodilo za uporabo.
English: For more information about using Stayveer, see the package leaflet or contact your doctor or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila Stayveer glejte navodilo za uporabo ali se posvetujte z zdravnikom ali farmacevtom.
English: Stayveer must not be used in patients who have certain liver problems, who are pregnant or could become pregnant and who are not using reliable contraceptive methods or who are taking ciclosporin (a medicine that acts on the immune system).
Slovenian: Zdravilo Stayveer se ne sme uporabljati pri bolnikih, ki imajo določene težave z jetri, bolnicah, ki so noseče ali bi lahko zanosile in ki ne uporabljajo zanesljivih metod preprečevanja zanositve, ter bolnikih, ki jemljejo ciklosporin (zdravilo, ki učinkuje na imunski sistem).
English: The company that makes Stayveer will provide a patient alert card to remind patients of the need for regular blood tests for liver function and to use effective contraception to avoid pregnancy.
Slovenian: Podjetje, ki izdeluje zdravilo Stayveer, bo zagotovilo opozorilno kartico za bolnike glede nujnega izvajanja rednih krvnih preiskav delovanja jeter in uporabo učinkovitega kontracepcijskega sredstva za preprečitev nosečnosti.
English: Side effects reported with Stayveer are carefully evaluated and any necessary action taken to protect patients.
Slovenian: Neželeni učinki, o katerih so poročali pri zdravilu Stayveer, se skrbno ovrednotijo in po potrebi se sprejmejo ukrepi za zaščito bolnikov.
English: The company that makes Tracleer has agreed that its scientific data can be used for Stayveer (‘informed consent').
Slovenian: Podjetje, ki proizvaja zdravilo Tracleer, se strinja, da se lahko znanstveni podatki o tem zdravilu uporabijo tudi za zdravilo Stayveer („uporaba dokumentacije s soglasjem“).
English: The most common side effects with Stayveer (which may affect more than 1 in 10 people) are headache, fluid retention, anaemia (low levels of haemoglobin, the protein in red blood cells that carries oxygen around the body) and abnormal results of blood tests to check the liver.
Slovenian: Najpogostejši neželeni učinki zdravila Stayveer (ki se lahko pojavijo pri več kot 1 od 10 bolnikov) so glavobol, zastajanje tekočine, anemija (nizke ravni hemoglobina, beljakovine v rdečih krvnih celicah, ki po telesu prenaša kisik) in nenormalni izvidi krvnih preiskav delovanja jeter.
English: Why is Stayveer authorised in the EU?
Slovenian: Zakaj je bilo zdravilo Stayveer odobreno v EU?
English: Stayveer is used to treat patients with class III pulmonary arterial hypertension (PAH) to improve exercise capacity (the ability to carry out physical activity) and reduce symptoms.
Slovenian: Zdravilo Stayveer se uporablja za zdravljenje bolnikov s pljučno arterijsko hipertenzijo (PAH) III. funkcijskega razreda za izboljšanje fizične zmogljivosti (sposobnosti izvajanja telesne dejavnosti) in zmanjševanje simptomov.
English: The active substance in Stayveer, bosentan, blocks a naturally occurring hormone called endothelin-1 (ET-1), which causes blood vessels to narrow.
Slovenian: Učinkovina v zdravilu Stayveer, bosentan, zavira naravno prisoten hormon, imenovan endotelin-1 (ET-1), ki povzroča zožitev krvnih žil.
English: • caused by scleroderma (also called systemic sclerosis, a disease where there is abnormal growth of the connective tissue that supports the skin and other organs);
Slovenian: • posledica skleroderme (imenovane tudi sistemska skleroza, tj. bolezen, pri kateri se nenormalno razrašča vezivno tkivo, ki daje oporo koži in drugim organom);
English: In the first study, patients taking Stayveer had an average of 1.4 new digital ulcers after 16 weeks, compared with 2.7 in the patients taking placebo.
Slovenian: V prvi študiji so imeli bolniki, ki so jemali zdravilo Stayveer, po 16 tednih zdravljenja povprečno 1,4 nove razjede prstov, bolniki, ki so jemali placebo, pa 2,7 nove razjede.
English: Stayveer can only be obtained with a prescription and treatment should only be started and monitored by a doctor who has experience in the treatment of PAH or systemic sclerosis.
Slovenian: Predpisovanje in izdaja zdravila Stayveer je le na recept, zdravljenje z njim pa lahko uvede in nadzoruje le zdravnik z izkušnjami z zdravljenjem pljučne arterijske hipertenzije ali sistemske skleroze.
English: The ‘class' reflects the severity of the disease: ‘class III' PAH involves marked limitation of physical activity.
Slovenian: Funkcijski razred odraža resnost bolezni: pljučna arterijska hipertenzija III. funkcijskega razreda vključuje izrazito omejitev telesne dejavnosti.
English: Stayveer can also be used in adults with systemic sclerosis in whom poor blood circulation caused by the disease has led to the development of digital ulcers (sores on the fingers and toes).
Slovenian: Zdravilo Stayveer se lahko uporablja tudi pri odraslih s sistemsko sklerozo, pri katerih je slab pretok krvi zaradi bolezni povzročil nastanek razjed prstov (razjed na prstih rok in nog).
English: However, Stayveer decreased the resistance to blood flow by 23%, indicating a widening of the blood vessels, compared with placebo after 6 months of treatment.
Slovenian: Zdravilo Stayveer pa je po šestih mesecih zdravljenja zmanjšalo upor krvnih žil za 23 %, kar kaže na razširitev krvnih žil v primerjavi s placebom.
English: Some improvement with Stayveer can also occur in patients with class II PAH.
Slovenian: Zdravilo Stayveer lahko nekoliko izboljša stanje tudi pri bolnikih s pljučno arterijsko hipertenzijo II.
English: In PAH, Stayveer added to patient's current therapy was more effective than placebo (a dummy treatment) in improving the distance patients could walk in 6 minutes (a way of measuring exercise capacity) after 16 weeks of treatment.
Slovenian: Pri pljučni arterijski hipertenziji je bilo zdravilo Stayveer kot dodatek k bolnikovemu trenutnemu zdravljenju po 16 tednih zdravljenja učinkovitejše od placeba (zdravila brez učinkovine) pri povečanju razdalje, ki jo bolniki lahko prehodijo v šestih minutah (način merjenja fizične zmogljivosti).
English: How is Stayveer used?
Slovenian: Kako se zdravilo Stayveer uporablja?
English: How does Stayveer work?
Slovenian: Kako zdravilo Stayveer deluje?
English: Stayveer is given to reduce the number of new digital ulcers.
Slovenian: Daje se za zmanjševanje števila novih razjed prstov.
English: Stayveer contains the active substance bosentan.
Slovenian: Zdravilo Stayveer vsebuje učinkovino bosentan.
English: Stayveer was more effective than placebo at reducing the development of new digital ulcers based on two studies in a total of 312 adults.
Slovenian: Zdravilo Stayveer je bilo v dveh študijah pri skupno 312 odraslih učinkovitejše od placeba pri zaviranju nastajanja novih razjed prstov.
English: In a study in 185 patients with class II disease the distance the patients could walk over 6 minutes was similar in the Stayveer and placebo groups.
Slovenian: funkcijskega razreda je bila razdalja, ki jo bolniki lahko prehodijo v šestih minutah, med skupinama, zdravljenima z zdravilom Stayveer oziroma placebom, podobna.
English: Stayveer therefore prevents blood vessels from narrowing.
Slovenian: Zdravilo Stayveer torej preprečuje zožitev krvnih žil.
English: For the full list of side effects of Stayveer, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Stayveer, glejte navodilo za uporabo.
English: <Do not use in ….>
Slovenian: <Ne uporabite v ...>
English: ANNEX II[Not applicable for MRP/DCP]
Slovenian: PRILOGA II[Not applicable for MRP/DCP]
English: OTHER INFORMATION>
Slovenian: DRUGE INFORMACIJE>
English: <Use only accordingly to the benefit-risk assessment by the responsible veterinarian.>
Slovenian: <Uporabite le v skladu z oceno razmerja korist-tveganje odgovornega veterinarja.>
English: ATC vet code: {lowest available level (e.g. subgroup for chemical substance)}.
Slovenian: Oznaka ATC vet: {najnižja razpoložljiva raven (npr. podskupina za kemijsko snov)}.
English: <Accidental injection is dangerous.>
Slovenian: <Nenamerno injiciranje je nevarno.>
English: <Dispose of waste material in accordance with local requirements.>
Slovenian: <Odpadne snovi odstranite v skladu z lokalnimi zahtevami.>
English: <This being an approval under exceptional circumstances and pursuant to Article 39(7) of Regulation (EC) No 726/2004, the MAH shall conduct, within the stated timeframe, the following measures:
Slovenian: <Ker gre za odobritev v izjemnih okoliščinah in ob upoštevanju člena 39(7) Uredbe (ES) št. 726/2004, mora imetnik dovoljenja za promet v spodaj navedenem časovnem okviru izvesti naslednje ukrepe:
English: <The periodic safety update report (PSUR) cycle should be restarted for submission of 6 monthly reports (covering all authorised presentations of the product) for the next two years, followed by yearly reports for the subsequent two years and thereafter at 3 yearly intervals.>[Only applicable, if justified after authorisation.]
Slovenian: <Cikel rednih posodobljenih poročil o varnosti zdravila (PSUR) se ponovno začne z oddajo šestmesečnih poročil (vključene so vse odobrene oblike zdravila) v obdobju naslednjih dveh let, ki mu sledi oddaja dveh letnih poročil za naslednji dve leti, po tem obdobju pa se poročila oddajajo v triletnih obdobjih.> [Only applicable, if justified after authorisation.]
English: Pharmacotherapeutic group: {group}.
Slovenian: Farmakoterapevtska skupina: {skupina}.
English: <Official control authority batch release is required for this product.> [only for those immunological veterinary medicinal products which are listed for HYPERLINK "https://www.edqm.eu/en/Veterinary-OCABR-Guidelines-1531.html" \l "PSG"Official Control Authority Batch Release (OCABR) in accordance with Article 82 of Directive 2001/82/EC as amended.]
Slovenian: <Za to zdravilo je potreben postopek uradne kontrole in sproščanja.> [only for those immunological veterinary medicinal products which are listed for HYPERLINK "https://www.edqm.eu/en/Veterinary-OCABR-Guidelines-1531.html" \l "PSG"Official Control Authority Batch Release (OCABR) in accordance with Article 82 of Directive 2001/82/EC as amended.]
English: <Specific pharmacovigilance requirements:>
Slovenian: <Posebne farmakovigilančne zahteve:>
English: <The long-term effects of the veterinary medicinal product on the population dynamics of dung beetles have not been investigated.
Slovenian: <Dolgoročni učinki tega zdravila na dinamiko populacije govnačev niso raziskani.
English: <According to Article 71 of Directive 2001/82/EC of the European Parliament and of the Council as amended, a Member State may, in accordance with its national legislation, prohibit the manufacture, import, possession, sale, supply and/or use of immunological veterinary medicinal products on the whole or part of its territory if it is established that:
Slovenian: <Skladno z 71. členom Direktive 2001/82/ES Evropskega parlamenta in Sveta z vsemi dopolnitvami in spremembami lahko država članica, skladno z nacionalno zakonodajo, prepove proizvajanje, uvoz/vnos, posedovanje, prodajo, oskrbo in/ali uporabo imunološkega zdravila za uporabo v veterinarski medicini na svojem celotnem ozemlju ali delu ozemlja, če ugotovi da:
English: Personnel involved in attending vaccinated {species} should follow general hygiene principles (changing clothes, wearing gloves, cleaning and disinfection of boots) and take particular care in handling animal waste and bedding materials from recently vaccinated {species}.>
Slovenian: Osebje, ki oskrbuje cepljene {živalske vrste} morajo upoštevati splošna higienska načela (menjava obleke, uporaba rokavic, čiščenje in razkuževanje čevljev) in mora še posebej paziti pri ravnanju z izločki in nastiljem {živalskih vrst}, ki so bile pred kratkim cepljene.>
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (HYPERLINK "http://www.ema.europa.eu/"http://www.ema.europa.eu/).
Slovenian: <Podrobne informacije o tem zdravilu so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency) ( HYPERLINK "http://www.ema.europa.eu/" http://www.ema.europa.eu/).>
English: <To the user:
Slovenian: <Namenjeno uporabniku:
English: b) the disease to which the product is intended to confer immunity is largely absent from the territory in question.>
Slovenian: b) bolezen, za katero se z zdravilom pridobi imunost, na zadevnem območju skoraj ni prisotna.>
English: <Not for use in birds producing or intended to produce eggs for human consumption.>
Slovenian: <Ni za uporabo pri pticah,ki proizvajajo ali so namenjene proizvodnji jajc za prehrano ljudi..>
English: <Any person intending to manufacture, import, possess, sell, supply and use this veterinary medicinal product must first consult the relevant Member State's competent authority on the current vaccination policies, as these activities may be prohibited in a Member State on the whole or part of its territory pursuant to national legislation.>
Slovenian: <Vsakdo, ki namerava proizvajati, uvažati oziroma vnašati, posedovati, prodajati, oskrbovati in uporabljati to zdravilo , se mora najprej posvetovati s pristojnim organom posamezne države članice o veljavnih programih cepljenja, saj so lahko te dejavnosti prepovedane v državi članici na njenem celotnem ozemlju ali delu ozemlja v skladu z nacionalno zakonodajo.>
English: <Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.>
Slovenian: <Vsako neporabljeno zdravilo za uporabo v veterinarski medicini ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi zahtevami.>
English: <PHARMACOLOGICAL><IMMUNOLOGICAL> PROPERTIES
Slovenian: <FARMAKOLOŠKE> <IMUNOLOŠKE> LASTNOSTI
English: <Do not use in breeding animals.>
Slovenian: <Ne uporabite pri vzrejnih živalih.>
English: · <SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR THE MARKETING AUTHORISATION UNDER EXCEPTIONAL CIRCUMSTANCES>
Slovenian: <SPECIFIČNE ZAHTEVE ZA IZPOLNITEV UKREPOV PO PRIDOBITVI DOVOLJENJA ZA PROMET Z ZDRAVILOM V IZJEMNIH OKOLIŠČINAH>
English: <No data available.>
Slovenian: <Ni podatkov.>
English: Pharmaco-logically active substanceMarker residueAnimal speciesMRLsTarget tissuesOther provisionsTherapeutic classification
Slovenian: Farmakološko aktivna snovMarker ostanekŽivalska vrstaMRLCiljna tkivaDruge določbeTerapevtske indikacije
English: <{DD month YYYY}>
Slovenian: <{DD mesec LLLL}>
English: <{X} degree days.>
Slovenian: <{X} dnevnih stopinj.>
English: <For any information about this veterinary medicinal product, please contact the local representative of the marketing authorisation holder.
Slovenian: <Za vse nadaljnje informacije o tem zdravilu se obrnite na krajevno predstavništvo imetnika dovoljenja za promet z zdravilom.>
English: The active substance being a principle of biological origin intended to <produce> <active><passive><diagnose a state of> immunity is not within the scope of Regulation (EC) No 470/2009.
Slovenian: Učinkovina, ki je v osnovi biološkega izvora namenjena <vzbujanju> <aktivne> <pasivne> <diagnosticiranju> imunosti, ne spada v področje uporabe Uredbe(ES) št. 470/2009.
English: <The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.>
Slovenian: <V natisnjenem navodilu za uporabo zdravila mora biti navedeno ime in naslov proizvajalca, odgovornega za sproščanje zadevne serije.>
English: <Can be used during pregnancy.>
Slovenian: <Lahko se uporablja v obdobju brejosti.>
English: <Duration of immunity: {x years}>
Slovenian: <Trajanje imunosti: {x let}>
English: <Do not use within {X} weeks of the start of the laying period.>
Slovenian: <Ne uporabite v obdobju {X} tednov pred začetkom obdobja nesnosti.>
English: <Medicines should not be disposed of via wastewater or <household waste>.>
Slovenian: <Ne odvrzite zdravila v odpadno vodo ali <med gospodinjske odpadke>.>
English: <Appropriate veterinary and husbandry measures should be taken to avoid spread of the vaccine strain to susceptible species.>
Slovenian: <Potrebni so ustrezni veterinarski in živinorejski ukrepi, da bi preprečili širitev vakcinalnega seva na dovzetne živalske vrste.>
English: <Vaccinate healthy animals only.>
Slovenian: <Cepite samo zdrave živali.>
English: <The import, possession, sale, supply and/or use of this veterinary medicinal product may be prohibited in a Member State on the whole or part of its territory, see package leaflet for further information.>
Slovenian: <Uvoz/vnos, posedovanje, prodaja, oskrba in/ali uporaba tega zdravila je lahko v državi članici prepovedana na njenem celotnem ozemlju ali delu ozemlja; za nadaljnje informacije glej navodilo za uporabo.>
English: <Date of last renewal:> <{DD/MM/YYYY}> <{DD month YYYY}.>
Slovenian: <Datum zadnjega podaljšanja dovoljenja za promet:> <{DD/MM/LLLL}> <{DD mesec LLLL}.>
English: <Do not use in cases of hypersensitivity to the active substance(s)<, to the adjuvant(s)> or to any of the excipient(s).>
Slovenian: <Ne uporabite v primerih preobčutljivosti na učinkovino(e) <, na dodatek(dodatke)> ali na katero koli pomožno snov.>
English: <Do not use {name of product} if you notice {description of the visible signs of deterioration}.>
Slovenian: <Ne uporabite {ime zdravila}, če opazite {opis vidnih znakov kvarjenja}.>
English: <Do not use in <birds in lay><breeding birds> <and within 4 weeks before the start of the laying period>.>
Slovenian: <Ne uporabite <pri pticah v obdobju nesnosti> <vzrejnih pticah> <in 4 tedne pred začetkom obdobja nesnosti.>
English: {(Invented) name of veterinary medicinal product <strength> pharmaceutical form}
Slovenian: {(Izmišljeno) ime zdravila za uporabo v veterinarski medicini <jakost> farmacevtska oblika}
English: DescriptionDue date>>
Slovenian: OpisDo datuma>
English: <In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.>
Slovenian: <Zaradi pomanjkanja študij kompatibilnosti tega zdravila ne smemo mešati z drugimi zdravili za uporabo v veterinarski medicini.>
English: <Do not use in pregnant animals which are intended to produce milk for human consumption within {X} months of expected parturition.>
Slovenian: <Ne uporabite pri brejih živalih, katerih mleko je namenjeno prehrani ljudi, v obdobju {X} mesecev pred pričakovanim porodom.>
English: · CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Slovenian: POGOJI ALI OMEJITVE V ZVEZI Z VARNO IN UČINKOVITO UPORABO ZDRAVILA
English: <People with known hypersensitivity to {INN} should <avoid contact with the veterinary medicinal product.><administer the veterinary medicinal product with caution.>>
Slovenian: <Osebe z znano preobčutljivostjo na {INN} naj <se izogibajo stiku z zdravilom.> <zdravilo dajejo previdno.>>
English: <Do not mix with any other veterinary medicinal product<, except <solvent or other component> <recommended><supplied> <for use with the veterinary medicinal product>.>
Slovenian: <Ne mešajte z nobenim drugim zdravilomza uporabo v veterinarski medicini <, razen z vehiklom ali drugo komponento> <, ki je priporočena> <, ki je priložena> < za uporabo s tem zdravilom>.>
English: <<Meat and offal><Eggs><Milk> <Honey>: {X} <days><hours>.>
Slovenian: <<Meso in organi> <Mleko> <Jajca> <Med>: {X} <ur><dni>.>
English: <{Species} and unvaccinated {species} in contact with vaccinated {species} may react to the vaccine strain, presenting clinical signs such as ….>
Slovenian: <{Živalske vrste} in necepljene {živalske vrste} lahko v stiku s cepljenimi {živalskimi vrstami} reagirajo na vakcinalni sev in pri tem kažejo klinične znake kot npr…>
English: <The <vaccine><immunological veterinary medicinal product><veterinary medicinal product> should not be used if {description of the visible signs of deterioration}.>
Slovenian: <Cepiva> <imunološkega zdravila> <zdravila> ne smemo uporabiti če {opis vidnih znakov kvarjenja}.>
English: <In case of accidental <self-administration><self-injection><ingestion><spillage onto skin>, seek medical advice immediately and show the package leaflet or the label to the physician.>
Slovenian: <V primeru nenamerne(ga) <samo-aplikacije> <samo-injiciranja> <zaužitja> <razlitja po koži> se takoj posvetujte z zdravnikom in mu pokažite navodila za uporabo ali ovojnino.>
English: <Do not use (during the whole or part of the pregnancy).>
Slovenian: <Ne uporabite (v celotnem ali delnem obdobju brejosti).>
English: <The use is not recommended (during the whole or part of the pregnancy).>
Slovenian: <Uporaba ni priporočljiva (v celotnem ali delnem obdobju brejosti).>
English: <Store in a refrigerator (2 (C - 8 (C).>
Slovenian: <Shranjujte v hladilniku (2 (C - 8 (C).>
English: <Disposal: read package leaflet.>
Slovenian: <Odstranjevanje: preberite navodilo za uporabo.>
English: <Environmental properties>
Slovenian: <Okoljski podatki>
English: <The MAH shall complete, within the stated timeframe, the following measures:
Slovenian: <Imetnik dovoljenja za promet z zdravilom mora v spodaj navedenem časovnem okviru izvesti naslednje ukrepe:
English: Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.>
Slovenian: Potreben je strokoven, TAKOJŠEN, kirurški poseg ter morda tudi takojšnja incizija in izpiranje injiciranega mesta, zlasti če so prizadete tudi kite ali mehka tkiva prsta.>
English: The Committee for Medicinal Products for Veterinary Use has recommended the inclusion of {name of the active substance(s)} in {name of the product} in table 1 (Allowed substances) of the annex to Commission Regulation (EU) No 37/2010 as follows:
Slovenian: Odbor za zdravila za uporabo v veterinarski medicini je priporočil vključitev {ime učinkovine} v {ime zdravila} v tabelo 1 (dovoljene snovi) priloge Uredbe Komisije (EU) št. 37/2010:
English: <5.2 Pharmacokinetic particulars>
Slovenian: <5.2 Farmakokinetični podatki>
English: <Once <broached><opened><diluted><reconstituted> <use by…> <use within…> <use immediately>.>
Slovenian: <Načeto> <odprto> <razredčeno> <rekonstituirano> zdravilo uporabite do…> <uporabite v…> <uporabite takoj>.>
English: <Not authorised for use in animals producing milk for human consumption.>
Slovenian: <Ni dovoljena uporaba pri živalih, katerih mleko je namenjeno prehrani ljudi.>
English: <The <veterinary medicinal product><vaccine><immunological veterinary medicinal product> should be given at different sites.>
Slovenian: <To <zdravilo> <cepivo> < imunološko zdravilo> se daje na različna mesta.>
English: <The use is not recommended during <pregnancy><lactation>.>
Slovenian: <Uporaba ni priporočljiva v obdobju <brejosti> <laktacije>.>
English: During this time, the contact of immunosuppressed and unvaccinated {species} with vaccinated {species} should be avoided.>
Slovenian: V tem času se je treba izogibati stikom imunsko oslabljenih {živalskih vrst} in necepljenih {živalskih vrst} s cepljenimi {živalskimi vrstami}.>